TWA
PDLI

TCI Wealth Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History

TCI Wealth Advisors’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-887
Closed -$3K – 1735
2020
Q2 		$3K Hold
887
– – ﹤0.01% 1008
2020
Q1 		$3K Hold
887
– – ﹤0.01% 958
2019
Q4 		$3K Buy
887
+88
+11% +$255 ﹤0.01% 1083
2019
Q3 		$2K Buy
+799
New +$2.14K ﹤0.01% 1204
2018
Q2 		– Sell
-295
Closed -$1K – 1690
2018
Q1 		$1K Buy
295
+77
+35% +$210 ﹤0.01% 1333
2017
Q4 		$1K Buy
+218
New +$670 ﹤0.01% 1359
2016
Q3 		– Sell
-180
Closed -$1K – 1469
2016
Q2 		$1K Sell
180
-176
-49% -$587 ﹤0.01% 1271
2016
Q1 		$1K Buy
+356
New +$1.11K ﹤0.01% 1283

Other funds holding PDLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return